Medtronic Insulin Pumps Vulnerable To Cybersecurity Attacks
Medtronic’s MiniMed series insulin pumps could allow unauthorized hackers to change the amount of insulin delivered to a patient, the FDA says.
You may also be interested in...
The US FDA has designated an April recall of tens of thousands of Medtronic devices as class I due to the potential of airway obstruction during surgery.
The US FDA is alerting device users about cybersecurity issues concerning the Axeda agent and Axeda Desktop Server, web-based technologies manufactured by Boston-based computer software company PTC that are used in numerous medical devices. Separately, a Palo Alto study revealed that infusion pumps are under cyber threat.
The missive reflects quality systems issues at the Northridge, CA headquarters of Medtronic’s diabetes division. Analysts are split on what the warning letter’s long-term impact may be.